A Which? review of 26 menopause supplements found none met criteria for a Best Buy, concluding they offer no better targeted support than standard multivitamins.
On September 30, 2026, the consumer group Which? published a review of 26 supplements marketed to midlife women, concluding that none of the products combined nutrients at appropriate doses to support use specifically for menopause.
Before recent consumer investigations challenged retail assumptions, the medical and lifestyle consensus encouraged a highly segmented approach to midlife nutrition. The supplement industry successfully established a dominant market for products exclusively branded for women navigating the hormonal transition. For years, the prevailing paradigm suggested that standard nutritional support was insufficient for this life stage. Consumers were directed toward complex formulations that routinely combine basic vitamins with botanicals.
Common botanical additions include black cohosh, soy, red clover, sage and St John’s wort. This approach created an environment where women felt compelled to purchase premium blends to manage their changing physiology. Marketing narratives consistently framed these expensive combinations as a necessary defense against shifting energy levels. The assumption held firm that an all-in-one product would naturally offer superior clinical support compared to a basic dietary supplement.
This belief shaped purchasing habits and influenced how women approached their nutritional routines. Many assumed that a higher financial investment correlated directly with better physical outcomes. The retail landscape rapidly expanded to accommodate this specialized consumer demand. Major retailers, including Boots, Holland & Barrett and Amazon, stocked their shelves with countless options promising tailored relief.
Women searching for practical guidance frequently encountered aggressive advertising rather than objective medical facts. The wellness industry capitalized on the genuine confusion surrounding which physical changes are hormonal and which have multiple causes. Consequently, highly priced supplements became the default recommendation in many commercial spaces. Women are frequently overwhelmed by health content that treats every physical change as a supplement opportunity.
Reading through perimenopause, menopause and hormonal change articles often reveals a stark contrast between medical consensus and retail marketing. The wellness industry positions its premium offerings as the ultimate solution for midlife, sidelining the true value of foundational nutrition. This commercial pressure creates an environment where women feel they must buy into a specialized product ecosystem to age successfully. The regulatory framework governing these products differs significantly from the medical oversight applied to prescription treatments.
Supplements are regulated strictly as foods in the UK, requiring compliance with food-safety, labelling and health-claims rules. Medicinal claims fall under the strict purview of the Medicines and Healthcare products Regulatory Agency. Trading Standards and the Advertising Standards Authority also manage enforcement and advertising compliance. This fragmented regulatory environment allowed premium brands to market complex formulations without providing rigorous clinical proof.
The consumer investigation brought specific data to a market historically driven by commercial claims. Researchers assessed the evidence for more than 78 active ingredients across 26 different supplements. The methodology rigorously evaluated the included ingredients, the existing evidence for their use, the specific doses provided and the presence of additives. The review was conducted by Which?’s nutritionist, Shefalee Loth, alongside consultant dietitian Sophie Medlin.
They established clear findings regarding both product efficacy and financial cost. The primary conclusion fundamentally challenges the necessity of premium blends in midlife care. None of the 26 reviewed products met the consumer group's criteria for a Best Buy recommendation. The investigation found that absolutely no product provided an evidence-based combination of nutrients at appropriate doses for menopause-specific benefits.
This finding directly contradicts the marketing strategies employed by many prominent wellness brands. The financial gap between heavily marketed blends and standard nutritional support is substantial. The consumer group suggested that a standard multivitamin, supplemented with targeted nutrients only where explicitly needed, may cost less and be more effective. The investigation used Asda A-Z Multivitamins & Minerals as a baseline price comparison.
The review distinguished between the marketing appeal of these products and their actual physiological value. While the packaging often highlights specific midlife concerns, the nutritional reality inside the bottle frequently falls short of clinical expectations. This disconnect highlights a significant issue within the broader wellness industry. Companies are legally permitted to market specialized blends, but consumers bear the burden of verifying whether the specific nutrient combinations justify the exorbitant price tags.
The review reported that the basic Asda option costs just 6p a day, or £22 a year. It contains standard vitamins alongside 200mg of calcium and 100mg of magnesium. By comparison, the most expensive product in the review commanded a massive premium. Which? reported that Love Mushrooms Empower costs £1.33 per day, or £485.45 over a year, for its recommended two-tablet dose.
The reviewers stated that this expensive formulation lacked menopause-specific nutrients, including calcium and magnesium. They also noted that the dose of lion’s mane extract included in the product was simply too low to be effective. The consumer group noted that Love Mushrooms did not respond to requests for comment regarding these findings. Other premium brands faced similar scrutiny regarding their cost-to-benefit ratios.
Wild Nutrition Women’s 45+ Daily Multi Nutrient was reported to cost £1.27 a day, or £468 a year. The report stated that it contained 1.5µg of vitamin D, 60mg of calcium and 30mg of magnesium. The reviewers noted these specific amounts fell below NHS-recommended daily intakes. Wild Nutrition responded to the investigation by stating its formulations are intended to complement a balanced diet and healthy lifestyle.
The company recommended that consumers speak with a qualified nutrition expert about individual needs. Even the product that performed best in the assessment highlighted the significant price disparity. Vitabiotics Menopace Max emerged as the highest-scoring product in the investigation. It costs 93p per day, or £340 a year, which is more than 15 times the daily cost of the standard Asda multivitamin.
Which? noted that both products provided the exact same amounts of vitamin D and magnesium, while Menopace Max provided a higher dose of calcium. Beyond cost, the review identified concerning patterns in how these dietary supplements are formulated. The investigators found that some products included key ingredients at doses they judged too low to be beneficial. The consumer group referred to this practice of low-dose inclusion as "fairy-dusting."
This tactic allows brands to list attractive ingredients on their labels without providing a clinically meaningful amount. Other formulations completely omitted nutrients that the reviewers identified as highly relevant to bone health, specifically calcium and vitamin D. The review also drew a sharp distinction between the evidence supporting basic nutrients and the evidence for complex botanicals. Researchers reported stronger evidence for specific vitamins and minerals, but found the evidence for many botanical ingredients remains decidedly mixed.
Products frequently provide botanical doses well below the amounts used in clinical trials. A lengthy ingredient list does not guarantee that a product will effectively relieve physical symptoms. Shoppers are advised to consider what they actually need rather than assume a higher price means greater effectiveness. Several companies offered specific responses to the consumer group's published findings.
Holland & Barrett disputed the characterization of its own-brand menopause products. The retailer stated its formulations are designed for the nutritional needs associated with this life stage. They maintained that the products contain meaningful, evidence-based levels of key vitamins and minerals. MyVitamins explained that its MenoSure product is a multi-ingredient formulation, stating that individual components are not intended to be used at standalone-supplement levels.
The brand added that it does not claim vitamins B1, B2 or B7 treat or alleviate symptoms. Health & Her did not offer a response to the review. Safety considerations remain a critical factor when evaluating these products. The consumer group cautions that botanical ingredients require careful management and oversight.
Consumers should check with a doctor or pharmacist before taking new herbal products. This step is particularly important for individuals managing underlying medical conditions or taking prescription medication. Botanical extracts can cause unintended interactions, complicating broader health management. Furthermore, a dietary supplement should never replace clinical care for persistent symptoms.
The consumer group explicitly states that supplements are not a substitute for hormone replacement therapy (HRT). Supplements are potentially relevant to nutrient intake and mild symptom relief, while HRT directly addresses systemic hormone levels. The two approaches may be used alongside one another, but only after a health professional has checked for interactions. The headline comparison from the review remains completely narrow in scope.
The investigation found that none of the 26 blends qualified as a Best Buy under its specific assessment criteria. This finding does not establish that all supplements are completely ineffective, nor does it prove that every standard multivitamin is entirely equivalent. Prices and formulations in this market remain subject to change based on retail promotions. The cost comparisons reflect the recommended servings and retail prices documented during the specific review period.
Navigating this complex retail landscape requires a clear-headed approach to personal health. Finding reliable guidance in nutrition and weight management articles demands separating commercial claims from actual measured results. A product’s packaging might promise a comprehensive solution, but the actual ingredient panel often tells a very different story. Women must critically assess whether a specific nutrient need has been clinically identified before investing in expensive daily regimens.
Maintaining physical resilience relies on consistent habits, a principle often detailed in strength, body composition and metabolism articles. Prioritizing internal health during midlife means looking past superficial wellness trends to focus on verified physiological requirements. A basic multivitamin might provide the exact foundational support a woman needs without the premium markup. When specific deficiencies are identified by a medical professional, targeted single-ingredient supplements often offer a safer and more cost-effective approach.
Going forward, clinical guidance will increasingly direct midlife women away from premium multi-ingredient botanicals and toward targeted, single-nutrient supplementation alongside evidence-based medical therapies.
Assessing the true value of premium nutritional formulations demands objective analysis rather than reliance on retail packaging claims. Refemina clarifies the complex realities of changes in strength, muscle, body composition, metabolism or weight by anchoring physical midlife transitions in established clinical research.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources